BioCentury | Apr 15, 2013
Company News

Heartland BioTechnologies LLC, Molecular Geriatrics deal

...Molecular Geriatrics acquired Heartland's technology for developing yeast-based assays for human G-protein coupled receptors. Molecular Geriatrics said...
...genes related to Alzheimer's disease (see BioCentury, March 31). Heartland BioTechnologies LLC , Davenport, Iowa Molecular Geriatrics Corp....
BioCentury | Sep 16, 2002
Company News

Hemoxymed, Molecular Geriatrics deal

...announced merger with Molecular Geriatrics (see BioCentury, Aug. 5). HMYD issued 22.8 million shares, thus valuing Molecular Geriatrics...
...and will be controlled by Molecular Geriatrics’s board and management. Hemoxymed Inc. (HMYD), New York, N.Y. Molecular Geriatrics Corp....
BioCentury | Aug 5, 2002
Company News

Hemoxymed, Molecular Geriatrics deal

...HMYD, which is developing its Hemoxygenation technology to increase tissue oxygenation, plans to merge with Molecular Geriatrics...
...and will be controlled by Molecular Geriatrics's board and management. Hemoxymed Inc. (HMYD), New York, N.Y. Molecular Geriatrics Corp....
BioCentury | May 20, 2002
Company News

Molecular Geriatrics other research news

...the arginine polymophism, leading the authors to suggest that STH has a role in AD. Molecular Geriatrics Corp....
BioCentury | Nov 20, 2000
Company News

Molecular Geriatrics other research news

...combinatorial chemistry and screening for compounds that inhibit formation of neurofibrillary tangles and amyloid plaques. Molecular Geriatrics Corp....
BioCentury | Mar 31, 1997
Company News

Gene Logic, Molecular Geriatrics deal

...related to Alzheimer's disease using Gene Logic's Accelerated Target Discovery platform with brain tissue from Molecular Geriatrics...
...Gene Logic intends to license the drug targets and lead compounds to pharmaceutical partners, while Molecular Geriatrics...
...partnering or other commercialization of therapeutics resulting from the collaboration Gene Logic Inc., Columbia, Md. Molecular Geriatrics Corp....
BioCentury | Jan 20, 1997
Company News

Avigen management update

Avigen Inc. (AVGN), Alameda, Calif. Business: Gene/Cell therapy Hired: Robert Maurer, vice president of business development; formerly COO of Molecular Geriatric Corp. WIR Staff...
BioCentury | Oct 16, 1995
Company News

Molecular Geriatrics, The Upjohn Co. deal

...Upjohn (Kalamazoo, Mich.) acquired Molecular Geriatrics' assay to detect Alzheimer's Disease Associated Protein (ADAP). An excess of...
...Upjohn will use the technology to screen compounds it is developing to treat the disease. Molecular Geriatrics...
...company an Alzheimer's diagnostic and exclusive rights to certain Alzheimer's compounds discovered by the company. Molecular Geriatrics Corp....
BioCentury | Feb 21, 1995
Finance

Blech holdings put into fund

...private company holdings in the portfolio are Cell Therapeutics Inc. , Alexion Pharmaceuticals Inc. and Molecular Geriatrics Corp....
Items per page:
1 - 9 of 9
BioCentury | Apr 15, 2013
Company News

Heartland BioTechnologies LLC, Molecular Geriatrics deal

...Molecular Geriatrics acquired Heartland's technology for developing yeast-based assays for human G-protein coupled receptors. Molecular Geriatrics said...
...genes related to Alzheimer's disease (see BioCentury, March 31). Heartland BioTechnologies LLC , Davenport, Iowa Molecular Geriatrics Corp....
BioCentury | Sep 16, 2002
Company News

Hemoxymed, Molecular Geriatrics deal

...announced merger with Molecular Geriatrics (see BioCentury, Aug. 5). HMYD issued 22.8 million shares, thus valuing Molecular Geriatrics...
...and will be controlled by Molecular Geriatrics’s board and management. Hemoxymed Inc. (HMYD), New York, N.Y. Molecular Geriatrics Corp....
BioCentury | Aug 5, 2002
Company News

Hemoxymed, Molecular Geriatrics deal

...HMYD, which is developing its Hemoxygenation technology to increase tissue oxygenation, plans to merge with Molecular Geriatrics...
...and will be controlled by Molecular Geriatrics's board and management. Hemoxymed Inc. (HMYD), New York, N.Y. Molecular Geriatrics Corp....
BioCentury | May 20, 2002
Company News

Molecular Geriatrics other research news

...the arginine polymophism, leading the authors to suggest that STH has a role in AD. Molecular Geriatrics Corp....
BioCentury | Nov 20, 2000
Company News

Molecular Geriatrics other research news

...combinatorial chemistry and screening for compounds that inhibit formation of neurofibrillary tangles and amyloid plaques. Molecular Geriatrics Corp....
BioCentury | Mar 31, 1997
Company News

Gene Logic, Molecular Geriatrics deal

...related to Alzheimer's disease using Gene Logic's Accelerated Target Discovery platform with brain tissue from Molecular Geriatrics...
...Gene Logic intends to license the drug targets and lead compounds to pharmaceutical partners, while Molecular Geriatrics...
...partnering or other commercialization of therapeutics resulting from the collaboration Gene Logic Inc., Columbia, Md. Molecular Geriatrics Corp....
BioCentury | Jan 20, 1997
Company News

Avigen management update

Avigen Inc. (AVGN), Alameda, Calif. Business: Gene/Cell therapy Hired: Robert Maurer, vice president of business development; formerly COO of Molecular Geriatric Corp. WIR Staff...
BioCentury | Oct 16, 1995
Company News

Molecular Geriatrics, The Upjohn Co. deal

...Upjohn (Kalamazoo, Mich.) acquired Molecular Geriatrics' assay to detect Alzheimer's Disease Associated Protein (ADAP). An excess of...
...Upjohn will use the technology to screen compounds it is developing to treat the disease. Molecular Geriatrics...
...company an Alzheimer's diagnostic and exclusive rights to certain Alzheimer's compounds discovered by the company. Molecular Geriatrics Corp....
BioCentury | Feb 21, 1995
Finance

Blech holdings put into fund

...private company holdings in the portfolio are Cell Therapeutics Inc. , Alexion Pharmaceuticals Inc. and Molecular Geriatrics Corp....
Items per page:
1 - 9 of 9